← Open Payments lookup

PAMELA MACLAUGHLIN: Open Payments

NPI 1003671967 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$256 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $151 · 2025 $256

Food & beverage: $256
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.2$48
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$47
ABBVIE INC.2$39
Alkermes, Inc.2$34
Teva Pharmaceuticals USA, Inc.1$25
Noven Therapeutics, LLC1$24
Otsuka America Pharmaceutical, Inc.1$21
Supernus Pharmaceuticals, Inc.1$19

Products named: COBENFY, CAPLYTA, VRAYLAR, ARISTADA, AUSTEDO XR, Secuado, REXULTI, Qelbree.

Industry payments across IN — which companies pay providers there.